Skip to main content

C3ai Inc

For the period ended Jan 31, 2024. Filed Feb 29, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jan 31, 2024 · Filed Feb 29, 2024

AI$11.84-1.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity

Three Months Ended January 31, 2024
Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’Equity
Shares · Amount
Balance as of October 31, 2023119,653$119$1,856,307$(775)$(944,375)$911,276
Issuance of Class A common stock upon exercise of stock options, net of repurchases283—1,209——1,209
Vesting of early exercised Class A common stock options——112——112
Shares withheld related to net share settlement of equity awards(30)—(720)——(720)
Vesting of restricted stock units1,721213,004——13,006
Stock-based compensation expense——44,538——44,538
Other comprehensive income———1,205—1,205
Net loss————(72,631)(72,631)
Balance as of January 31, 2024121,627$121$1,914,450$430$(1,017,006)$897,995
Nine Months Ended January 31, 2024
Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Income · Accumulated Deficit · Total Stockholders’Equity
Shares · Amount
Balance as of April 30, 2023113,943$113$1,740,174$(385)$(810,237)$929,665
Issuance of Class A common stock upon exercise of stock options, net of repurchases2,534211,317——11,319
Vesting of early exercised Class A common stock options——406——406
Shares withheld related to net share settlement of equity awards(283)—(10,485)——(10,485)
Vesting of restricted stock units5,004534,470——34,475
Issuance of Class A common stock under employee stock purchase plan42915,054——5,055
Stock-based compensation expense——133,514——133,514
Other comprehensive income———815—815
Net loss————(206,769)(206,769)
Balance as of January 31, 2024121,627$121$1,914,450$430$(1,017,006)$897,995
Three Months Ended January, 2023
Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’Equity
Shares · Amount
Balance as of October 31, 2022110,101$110$1,637,980$(2,805)$(682,119)$953,166
Issuance of Class A common stock upon exercise of stock options, net of repurchases180—590——590
Vesting of early exercised Class A common stock options——286——286
Tax withholding related to net share settlement of equity awards(115)—(1,440)——(1,440)
Vesting of restricted stock units1,843210,253——10,255
Stock-based compensation expense——45,905——45,905
Other comprehensive income———1,770—1,770
Net loss————(63,162)(63,162)
Balance as of January 31, 2023112,009$112$1,693,574$(1,035)$(745,281)$947,370
Nine Months Ended January, 2023
Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’Equity
Shares · Amount
Balance as of April 30, 2022106,225$106$1,532,917$(2,148)$(541,398)$989,477
Issuance of Class A common stock upon exercise of stock options, net of repurchases74712,386——$2,387
Vesting of early exercised Class A common stock options——842——$842
Tax withholding related to net share settlement of equity awards(336)—(4,815)——$(4,815)
Vesting of restricted stock units5,373523,923——$23,928
Stock-based compensation expense——138,321——$138,321
Other comprehensive income———1,113—$1,113
Net loss————(203,883)$(203,883)
Balance as of January 31, 2023112,009$112$1,693,574$(1,035)$(745,281)$947,370
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.